Business
Currency:USD
2025/Q3
Stock NameRevenueRatio
Sterilization and Disinfection Control23.51M37.41%
Calibration Solutions14.43M22.96%
Clinical Genomics12.67M20.16%
Biopharmaceutical Development12.24M19.47%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States106.4M49.21%
Other84.86M39.25%
People's Republic of China24.93M11.53%